RSV and premature babies
Premature babies — those born before 37 weeks gestation — are among the highest-risk infants for severe RSV. Their lungs are smaller and less developed, their immune systems are immature, and many spent early weeks in the NICU building lung function that full-term infants have from birth. RSV, a virus that causes a mild cold in most adults, can send a premature baby into respiratory distress quickly.
If your baby was born early, understanding RSV risk and the protection available isn't optional — it's one of the most important things you can do before your first RSV season.
Why prematurity raises RSV risk
Several factors converge to make preemies more vulnerable:
- Underdeveloped lungs. The lungs complete much of their development in the final weeks of pregnancy. Babies born at 28–34 weeks have significantly fewer alveoli and less surfactant than full-term infants, leaving less respiratory reserve when illness hits.
- Smaller airways. Airways in preterm infants are physically narrower. When RSV causes airway inflammation and mucus, the same amount of swelling that barely affects a full-term infant can substantially reduce airflow in a premature baby.
- Reduced maternal antibodies. Most maternal antibodies transfer across the placenta in the third trimester. Babies born early receive fewer of these antibodies, leaving them with less passive immune protection.
- Chronic lung disease of prematurity (BPD). Babies who developed bronchopulmonary dysplasia from prolonged ventilator or oxygen use have ongoing lung vulnerability that can make any respiratory illness — RSV especially — more dangerous.
Beyfortus (nirsevimab) eligibility for premature babies
Beyfortus is a monoclonal antibody — not a vaccine — that provides passive protection against RSV for infants through their first RSV season. For premature babies, eligibility works slightly differently than for full-term infants.
Standard eligibility: All infants born during RSV season (approximately October through March) or entering their first RSV season under 8 months of age are eligible for one dose of Beyfortus.
For very premature infants (born before 29 weeks gestation): Beyfortus eligibility extends through the second RSV season — up to 24 months of age if the child remains at increased risk due to prematurity-related lung complications. This extended eligibility recognizes that premature babies' vulnerability doesn't resolve at 8 months the way a full-term infant's does.
Key point: Eligibility is based on gestational age at birth, not corrected age. A baby born at 28 weeks who is now 6 months old (4 months corrected) is still classified as a very premature infant for Beyfortus eligibility purposes.
For infants born at 29–35 weeks gestation: Standard Beyfortus eligibility applies (one dose, first RSV season), but your neonatologist or pediatrician may have additional guidance based on your baby's specific lung history.
When to get Beyfortus for a NICU graduate
For babies still in the NICU at the start of RSV season, the dose is typically given just before discharge — so your baby is protected from the moment they leave the hospital. For babies discharged before RSV season starts, the dose is given at the first well-child visit during RSV season (usually October or November).
If your baby was discharged in summer or early fall, confirm with your pediatrician that Beyfortus is on the schedule for the upcoming season. It's a single intramuscular injection and is typically administered alongside routine vaccinations.
If the maternal RSV vaccine (Abrysvo) was given during pregnancy
If you received the maternal RSV vaccine at 32–36 weeks gestation, your baby received antibodies across the placenta before birth. For premature babies born significantly before 32 weeks, this protection may be reduced — there simply wasn't enough time in utero to receive a full transfer. This is another reason Beyfortus is important for very premature infants: it provides the antibody protection that couldn't be passed before birth.
For babies born after 32 weeks whose mothers did receive Abrysvo, the current guidance is to discuss with your pediatrician or neonatologist whether Beyfortus is also indicated. There is no safety concern with receiving both — the question is whether the added protection is recommended for your specific baby's situation.
What to watch for during RSV season
Parents of premature babies should have a lower threshold for calling their pediatrician than parents of full-term infants. Signs to watch for that warrant same-day contact:
- Any fever above 100.4°F (38°C) — in a preemie, fever always warrants a call
- Breathing rate above 60 breaths/minute at rest
- Increased work of breathing — nostrils flaring, ribs showing, or a "seesaw" belly movement
- Color changes — pale, mottled, or blue around the lips
- Feeding less than half of normal over 24 hours
- SpO₂ below 95% on a pulse oximeter (many NICU discharge plans include one)
Go to the ER immediately if your premature baby shows labored breathing with visible retractions, persistent SpO₂ below 90%, blue or gray coloring, or pauses in breathing. Don't wait to see if it improves.
Reducing exposure during RSV season
In addition to Beyfortus, the most effective thing you can do is reduce your premature baby's exposure to RSV:
- Ask visitors to wash hands before holding the baby
- Keep the baby away from anyone with cold symptoms
- Limit crowded indoor settings (malls, daycare, large family gatherings) during peak RSV months
- If older siblings are in daycare or school — a major source of household RSV exposure — have them wash hands when they come home
RSV lives on surfaces for several hours and spreads easily through touching the face after contact with a contaminated surface. Hand hygiene — both for you and visitors — is genuinely effective.
Not medical advice. This guide is for educational purposes. Eligibility criteria for Beyfortus evolve — always confirm current guidance with your pediatrician or neonatologist. In an emergency, call 911.